News

Date
Summary

New international research suggests that too much calcium inside brain cells may trigger a chain reaction that leads to Parkinson's.

Date
Summary

We're partnering with US company Neurolixis to accelerate the development of a drug that could prevent dyskinesia, a debilitating side effect of Parkinson's medication.